In conclusion, the groundbreaking findings of the current study have unveiled a significant revelation regarding the influence of DPP-4 inhibitors and PACAP, a substrate of DPP-4, on the promotion of neurite outgrowth in DRG neurons, thereby shedding new light on potential therapeutic avenues for peripheral neuropathy. Here, ADCYAP1 is linked to peripheral neuropathy.